Skip to main content
Clinical Trials/IRCT20111206008307N38
IRCT20111206008307N38
Recruiting
Phase 2

Evaluation of quality of life in patients with heart failure treated with colchicine

Tabriz University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Tabriz University of Medical Sciences
Enrollment
60
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with heart failure
  • Patients with a history of cardiac ischemia
  • Patients with a history of thromboembolism
  • Patients with high serum levels of inflammatory factors in heart failure and cardiovascular problems
  • Patients with less renal glomerular filtration rate 30mm Hg /min/1\.73 m2
  • Patients with symptomatic hypotension and systolic pressure below 100 or above 180 mm Hg
  • Complete the consent form

Exclusion Criteria

  • Patients with heart failure who are treated on an outpatient basis and do not need to be hospitalized
  • Patients with heart failure are in the age group under 18 years and over 80 years
  • Patients with heart failure with colchicine allergy
  • Patients with heart failure who have not completed the consent form

Outcomes

Primary Outcomes

Not specified

Similar Trials